Correlation Between Biotage AB and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotage AB and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotage AB and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotage AB and CellaVision AB, you can compare the effects of market volatilities on Biotage AB and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotage AB with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotage AB and CellaVision.

Diversification Opportunities for Biotage AB and CellaVision

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biotage and CellaVision is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Biotage AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Biotage AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotage AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Biotage AB i.e., Biotage AB and CellaVision go up and down completely randomly.

Pair Corralation between Biotage AB and CellaVision

Assuming the 90 days trading horizon Biotage AB is expected to generate 1.62 times less return on investment than CellaVision. But when comparing it to its historical volatility, Biotage AB is 1.27 times less risky than CellaVision. It trades about 0.02 of its potential returns per unit of risk. CellaVision AB is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  19,950  in CellaVision AB on August 28, 2024 and sell it today you would earn a total of  2,200  from holding CellaVision AB or generate 11.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.52%
ValuesDaily Returns

Biotage AB  vs.  CellaVision AB

 Performance 
       Timeline  
Biotage AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotage AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CellaVision AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Biotage AB and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotage AB and CellaVision

The main advantage of trading using opposite Biotage AB and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotage AB position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Biotage AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format